Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters (original) (raw)
Ait-Daoud N, Roache JD, Dawes MA, Liu L, Wang XQ, Javors MA et al (2009). Can serotonin transporter genotype predict craving in alcoholism? Alcohol Clin Exp Res33: 1329–1335. ArticleCASPubMedPubMed Central Google Scholar
Anisman H (2009). Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci34: 4–20. PubMedPubMed Central Google Scholar
Apparsundaram S, Sung U, Price RD, Blakely RD (2001). Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J Pharmacol Exp Ther299: 666–677. CASPubMed Google Scholar
Arakawa H, Blandino Jr P, Deak T (2009). Central infusion of interleukin-1 receptor antagonist blocks the reduction in social behavior produced by prior stressor exposure. Physiol Behav98: 139–146. ArticleCASPubMedPubMed Central Google Scholar
Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT et al (2008). Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci USA105: 18976–18981. ArticleCASPubMedPubMed Central Google Scholar
Bencsics A, Elenkov IJ, Vizi ES (1995). Alpha 2-, alpha 2A-, alpha 2B/2C-adrenoceptor subtype antagonists prevent lipopolysaccharide-induced fever response in rabbits. Brain Res705: 302–306. ArticleCASPubMed Google Scholar
Blakely RD, Defelice LJ, Galli A (2005). Biogenic amine neurotransmitter transporters: just when you thought you knew them. Physiology (Bethesda)20: 225–231. CAS Google Scholar
Capuron L, Dantzer R (2003). Cytokines and depression: the need for a new paradigm. Brain Behav Immun17 (Suppl 1): S119–S124. ArticleCASPubMed Google Scholar
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science301: 386–389. ArticleCASPubMed Google Scholar
Castanon N, Bluthé RM, Dantzer R (2001). Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl)154: 50–60. ArticleCAS Google Scholar
Castanon N, Konsman JP, Medina C et al (2003). Chronic treatment with the antidepressant tianeptine attenuates lipopolysaccharide-induced Fos expression in the rat paraventricular nucleus and HPA axis activation. Psychoneuroendocrinology28: 19–34. ArticleCASPubMed Google Scholar
Chen R, Zhou H, Beltran J, Malellari L, Chang SL (2005). Differential expression of cytokines in the brain and serum during endotoxin tolerance. J Neuroimmunol163: 53–72. ArticleCASPubMed Google Scholar
Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev29: 571–625. ArticleCASPubMed Google Scholar
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci9: 46–56. ArticleCASPubMedPubMed Central Google Scholar
Daws LC, Toney GM (2007). High-Speed Chronoamperometry to Study Kinetics and Mechanisms for Serotonin Clearance In Vivo. CRC Press, Taylor & Francis Group: Boca Raton, FL. Google Scholar
Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV (2010). Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry8: 172–176. Article Google Scholar
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al (2010). A meta-analysis of cytokines in major depression. Biol Psychiatry67: 446–457. Epub 2009 Dec 16. ArticleCASPubMed Google Scholar
Dunn AJ, Swiergiel AH (2005). Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol Biochem Behav81: 688–693. ArticleCASPubMedPubMed Central Google Scholar
Firk C, Markus CR (2007). Serotonin by stress interaction: a susceptibility factor for the development of depression? J Psychopharmacol21: 538–544. ArticleCASPubMed Google Scholar
Gaspar P, Cases O, Maroteaux L (2003). The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci4: 1002–1012. ArticleCASPubMed Google Scholar
Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T et al (2008). Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry13: 717–728. ArticleCASPubMed Google Scholar
Gottschall PE, Komaki G, Arimura A (1992). Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide. Neuroendocrinology56: 935–938. ArticleCASPubMed Google Scholar
Guo AL, Petraglia F, Criscuolo M, Ficarra G, Salvestroni C, Nappi RE et al (1996). Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats. Gynecol Endocrinol10: 149–154. ArticleCASPubMed Google Scholar
Hall SR, Smith AP (1996). Behavioural effects of infectious mononucleosis. Neuropsychobiology33: 202–209. ArticleCASPubMed Google Scholar
Hollis JH, Evans AK, Bruce KP, Lightman SL, Lowry CA (2006). Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons. Brain Behav Immun20: 569–577. ArticleCASPubMed Google Scholar
Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med71: 171–186. Epub 2009 Feb 2. ArticleCASPubMed Google Scholar
Katafuchi T, Kondo T, Take S, Yoshimura M (2005). Enhanced expression of brain interferon-alpha and serotonin transporter in immunologically induced fatigue in rats. Eur J Neurosci22: 2817–2826. ArticlePubMed Google Scholar
Katafuchi T, Kondo T, Take S, Yoshimura M (2006). Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Ann N Y Acad Sci1088: 230–237. ArticleCASPubMed Google Scholar
Konsman JP, Veeneman J, Combe C, Poole S, Luheshi GN, Dantzer R (2008). Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci28: 2499–2510. ArticleCASPubMed Google Scholar
Koo JW, Duman RS (2008). IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA105: 751–756. ArticleCASPubMedPubMed Central Google Scholar
Koo JW, Duman RS (2009). Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr Opin Investig Drugs10: 664–671. CASPubMedPubMed Central Google Scholar
Koo JW, Duman RS (2009). Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett456: 39–43. ArticleCASPubMedPubMed Central Google Scholar
Laucht M, Treutlein J, Blomeyer D, Buchmann AF, Schmid B, Becker K et al (2009). Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. Int J Neuropsychopharmacol12: 737–747. ArticleCASPubMed Google Scholar
Lavicky J, Dunn AJ (1994). Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis. J Neurosci Res40: 407–413. Article Google Scholar
Lesch K-P (2001). Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord62: 57–76. ArticleCASPubMed Google Scholar
Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999). Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology40: 171–176. ArticleCASPubMed Google Scholar
Loppnow H, Libby P, Freudenberg M, Krauss JH, Weckesser J, Mayer H (1990). Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun58: 3743–3750. CASPubMedPubMed Central Google Scholar
Maes M (1999). Major depression and activation of the inflammatory response system. Adv Exp Med Biol461: 25–46. ArticleCASPubMed Google Scholar
Maier SF, Watkins KT (1995). Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res695: 279–286. ArticleCASPubMed Google Scholar
Meijer A, Zakay-Rones Z, Morag A (1988). Post-influenzal psychiatric disorder in adolescents. Acta Psychiatr Scand78: 176–181. ArticleCASPubMed Google Scholar
Minor TR, Huang Q, Witt AE (2006). Cytokine-purine interactions in traumatic stress, behavioral depression, and sickness. CNS Neurol Disord Drug Targets5: 547–560. ArticlePubMed Google Scholar
Mössner R, Daniel S, Schmitt A, Albert D, Lesch KP (2001). Modulation of serotonin transporter function by interleukin-4. Life Sci68: 873–880. ArticlePubMed Google Scholar
Mössner R, Heils A, Stöber G, Okladnova O, Daniel S, Lesch KP (1998). Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int33: 251–254. ArticlePubMed Google Scholar
Müller N, Schwarz MJ (2007). The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry12: 988–1000. ArticlePubMed Google Scholar
O’Connor JC, Lawson MA, André C, Moreau M, Lestage J, Castanon N et al (2009). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry14: 511–522. ArticlePubMed Google Scholar
Owen BM, Eccleston D, Ferrier IN, Young AH (2001). Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand103: 226–228. ArticleCASPubMed Google Scholar
Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J et al (2003). Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry8: 933–936. ArticleCASPubMed Google Scholar
Plata-Salamán CR, Borkoski JP (1993). Centrally administered bacterial lipopolysaccharide depresses feeding in rats. Pharmacol Biochem Behav46: 787–791. ArticlePubMed Google Scholar
Pollak Y, Ovadia H, Goshen I, Gurevich R, Monsa K, Avitsur R et al (2000). Behavioral aspects of experimental autoimmune encephalomyelitis. J Neuroimmunol104: 31–36. ArticleCASPubMed Google Scholar
Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009). Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci364: 163–173. ArticleCASPubMed Google Scholar
Qin L, He J, Hanes RN, Pluzarev O, Hong JS, Crews FT (2008). Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation5: 10. ArticlePubMedPubMed Central Google Scholar
Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol27: 24–31. ArticleCASPubMed Google Scholar
Ramamoorthy S, Ramamoorthy JD, Prasad PD, Bhat GK, Mahesh VB, Leibach FH et al (1995). Regulation of the human serotonin transporter by interleukin-1 beta. Biochem Biophys Res Commun216: 560–567. ArticleCASPubMed Google Scholar
Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S (2005). A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci25: 29–41. ArticleCASPubMedPubMed Central Google Scholar
Schmitt A, Mössner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL et al (2003). Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res71: 701–709. ArticleCASPubMed Google Scholar
Segal J, Schenkel LC, Oliveira MH, Salum GA, Bau CH, Manfro GG et al (2009). Novel allelic variants in the human serotonin transporter gene linked polymorphism (5-HTTLPR) among depressed patients with suicide attempt. Neurosci Lett451: 79–82. ArticleCASPubMed Google Scholar
Swiergiel AH, Dunn AJ (2007). Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav86: 651–659. ArticleCASPubMedPubMed Central Google Scholar
Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E (2003). Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl)170: 429–433. ArticleCAS Google Scholar
van den Biggelaar AH, Gussekloo J, de Craen AJ, Frölich M, Stek ML, van der Mast RC et al (2007). Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol42: 693–701. ArticleCASPubMed Google Scholar
Vaswani M, Linda FK, Ramesh S (2003). Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry27: 85–102. ArticleCASPubMed Google Scholar
Vergne DE, Nemeroff CB (2006). The interaction of serotonin transporter gene polymorphisms and early adverse life events on vulnerability for major depression. Curr Psychiatry Rep8: 447–452. Article Google Scholar
Yirmiya R (1996). Endotoxin produces a depressive-like episode in rats. Brain Res711: 163–174. ArticleCASPubMed Google Scholar
Yirmiya R, Pollak Y, Barak O, Avitsur R, Ovadia H, Bette M et al (2001). Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology24: 531–544. ArticleCASPubMed Google Scholar
Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R et al (2000). Illness, cytokines, and depression. Ann N Y Acad Sci917: 478–487. ArticleCASPubMed Google Scholar
Yirmiya R, Weidenfeld J, Pollak Y, Morag M, Morag A, Avitsur R et al (1999). Cytokines, ‘depression due to a general medical condition,’ and antidepressant drugs. Adv Exp Med Biol461: 283–316. ArticleCASPubMed Google Scholar
Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005). p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem280: 15649–15658. ArticleCASPubMed Google Scholar
Zhu CB, Hewlett WA, Blakely RD (2006). The proinflammatory cytokines interleukine-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology31: 2121–2131. ArticleCASPubMed Google Scholar